Maria Mercedes Pineyro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Maria Mercedes Pineyro has a total of 95 co-authors. Here are the top co-authors by number of shared publications:
Ramiro Lima
Neurocirugía, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay
4 shared publicationsRaul Pisabarro
Clínica de Endocrinología y Metabolismo Hospital de Clínicas Facultad de Medicina Universidad de la República Montevideo Uruguay
4 shared publicationsAmir H. Hamrahian
3 shared publications- Maria Fleseriu
Pituitary Center, Departments of Medicine and Neurological Surgery, Oregon Health & Science University, Portland, USA
3 shared publications - Ana Clara Casella
Universidad de la República, Facultad de Medicina, Hospital de Clínicas, Clínica de Endocrinología y Metabolismo
2 shared publications - Ann McCormack
Department of Endocrinology, St Vincent's Hospital Sydney , Sydney, NSW 2010
2 shared publications
Latest Publications
- 29 December 2025
- Published by Revista Medica del Uruguay in REVISTA MEDICA DEL URUGUAY
- Vol. 42 (1)
Hipopituitarismo congénito: diagnóstico y seguimiento a 10 años en el Servicio de Endocrinología del Hospital Pereira Rossell
- 29 December 2025
- Published by Revista Medica del Uruguay in REVISTA MEDICA DEL URUGUAY
- Vol. 42 (1)
Hipopituitarismo congénito: diagnóstico y seguimiento a 10 años en el Servicio de Endocrinología del Hospital Pereira Rossell
- Open Access
- 11 August 2025
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2025 (8)
Isolated syndrome of inappropriate antidiuresis (SIAD) after Transphenoidal surgery of a non-functioning pituitary adenoma: clinical case report
Introduction: Disorders of water balance, including arginine vasopressin deficiency (AVP-D) and syndrome of inappropriate antidiuresis (SIAD), are common postoperative complications following pituitary surgery. While AVP-D typically occurs as an isolated condition, SIAD may also present independently. Clinical Case: We describe the case of a patient with a non-functioning pituitary adenoma who underwent transsphenoidal surgery. On postoperative day 7, she developed isolated SIAD, characterized by a plasma sodium level of 113 mmol/L, normovolemia, urine osmolality of 364 mOsm/kg, and urine sodium concentration of 50 mmol/L. A daily fluid restriction of 800 mL resulted in the resolution of hyponatremia within 48 h. Conclusions: Water balance disorders following pituitary surgery are often unpredictable. This case highlighs the importance of close postoperative clinical and biochemical monitoring. Vigilance is essential, even in the absence of AVP-D, to ensure early detection and management of potentially severe complications such as SIAD.
- 11 August 2025
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2025 (8)
Open AccessIsolated syndrome of inappropriate antidiuresis (SIAD) after Transphenoidal surgery of a non-functioning pituitary adenoma: clinical case report
Introduction: Disorders of water balance, including arginine vasopressin deficiency (AVP-D) and syndrome of inappropriate antidiuresis (SIAD), are common postoperative complications following pituitary surgery. While AVP-D typically occurs as an isolated condition, SIAD may also present independently. Clinical Case: We describe the case of a patient with a non-functioning pituitary adenoma who underwent transsphenoidal surgery. On postoperative day 7, she developed isolated SIAD, characterized by a plasma sodium level of 113 mmol/L, normovolemia, urine osmolality of 364 mOsm/kg, and urine sodium concentration of 50 mmol/L. A daily fluid restriction of 800 mL resulted in the resolution of hyponatremia within 48 h. Conclusions: Water balance disorders following pituitary surgery are often unpredictable. This case highlighs the importance of close postoperative clinical and biochemical monitoring. Vigilance is essential, even in the absence of AVP-D, to ensure early detection and management of potentially severe complications such as SIAD.
- Open Access
- 31 January 2025
- Published by Wiley in Case Reports in Endocrinology
- Vol. 2025 (1) , 5388529
Arrested Puberty in a Young Adult With a Macroprolactinoma: Case Report and Literature Review
Prolactinoma is the most common pituitary tumor, with clinical presentations varying according to sex, age of onset, tumor size, and prolactin (PRL) levels. These tumors are rare in the pediatric and adolescent populations. Hyperprolactinemia leads to hypogonadotropic hypogonadism, resulting in reproductive, metabolic, sexual, and skeletal consequences that can affect puberty development. Here, we present the case of a 23‐year‐old male patient diagnosed with arrested puberty secondary to a macroprolactinoma. The clinical presentation, diagnostic approach, therapeutic management, and a literature review are discussed.
- 31 January 2025
- Published by Wiley in Case Reports in Endocrinology
- Vol. 2025 (1) , 5388529
Open AccessArrested Puberty in a Young Adult With a Macroprolactinoma: Case Report and Literature Review
Prolactinoma is the most common pituitary tumor, with clinical presentations varying according to sex, age of onset, tumor size, and prolactin (PRL) levels. These tumors are rare in the pediatric and adolescent populations. Hyperprolactinemia leads to hypogonadotropic hypogonadism, resulting in reproductive, metabolic, sexual, and skeletal consequences that can affect puberty development. Here, we present the case of a 23‐year‐old male patient diagnosed with arrested puberty secondary to a macroprolactinoma. The clinical presentation, diagnostic approach, therapeutic management, and a literature review are discussed.
- Open Access
- 7 January 2025
- Published by Wiley in Case Reports in Endocrinology
- Vol. 2025 (1) , 2490132
Microprolactinoma Growth During Pregnancy With Pituitary Tumor Apoplexy: Case Report and Review of the Literature
Prolactinomas are the most prevalent subtype of pituitary adenomas and represent one of the leading etiological factors responsible for amenorrhea and infertility in women. The primary therapeutic approach entails the use of dopamine agonists, which effectively restore fertility. In cases of microprolactinomas, the likelihood of experiencing a symptomatic enlargement of the tumor during pregnancy is exceptionally low, estimated at a mere 2.4%. Consequently, once pregnancy is successfully achieved, the administration of dopamine agonists is discontinued, with ongoing clinical monitoring of the patient’s condition. The incidence of pituitary apoplexy during pregnancy is exceedingly rare. We present a case of a 29‐year‐old patient with microprolactinoma, treated with cabergoline, which was discontinued upon achieving pregnancy. However, at the 16th week of gestation, she presented with persistent headaches and compromised visual acuity, manifesting as left temporal hemianopia. A noncontrast magnetic resonance imaging (MRI) revealed an enlargement of the adenoma, accompanied by evidence of hemorrhage. She was referred to our hospital at 26 weeks of gestation. Cabergoline treatment was reinstated and well tolerated by the patient. Doses were increased to 2 mg per week because bitemporal hemianopia was not improving. A subsequent noncontrast MRI scan performed at 35 weeks of gestation demonstrated a further increase in adenoma size, measuring 17 × 21 × 13 mm, with signs of intratumoral bleeding. A planned cesarean section was performed at 39 weeks of gestation, without encountering maternal–fetal complications. Breastfeeding was not initiated due to the adenoma’s compression of the chiasm. Accordingly, dopamine agonist therapy was continued. During the postpartum follow‐up, the patient experienced a resumption of menstrual cycles, normalization of prolactin levels, and a reduction in tumor size. Ultimately, the diagnosis was established as a microprolactinoma, which had enlarged during pregnancy due to a pituitary tumor apoplexy. Although microprolactinomas typically carry a low risk of symptomatic tumor growth during pregnancy, this case emphasizes the critical importance of vigilant clinical monitoring to swiftly detect and manage this rare complication. This instance serves as an educational example of an uncommon event—a microprolactinoma experiencing apoplexy during pregnancy.
- 7 January 2025
- Published by Wiley in Case Reports in Endocrinology
- Vol. 2025 (1) , 2490132
Open AccessMicroprolactinoma Growth During Pregnancy With Pituitary Tumor Apoplexy: Case Report and Review of the Literature
Prolactinomas are the most prevalent subtype of pituitary adenomas and represent one of the leading etiological factors responsible for amenorrhea and infertility in women. The primary therapeutic approach entails the use of dopamine agonists, which effectively restore fertility. In cases of microprolactinomas, the likelihood of experiencing a symptomatic enlargement of the tumor during pregnancy is exceptionally low, estimated at a mere 2.4%. Consequently, once pregnancy is successfully achieved, the administration of dopamine agonists is discontinued, with ongoing clinical monitoring of the patient’s condition. The incidence of pituitary apoplexy during pregnancy is exceedingly rare. We present a case of a 29‐year‐old patient with microprolactinoma, treated with cabergoline, which was discontinued upon achieving pregnancy. However, at the 16th week of gestation, she presented with persistent headaches and compromised visual acuity, manifesting as left temporal hemianopia. A noncontrast magnetic resonance imaging (MRI) revealed an enlargement of the adenoma, accompanied by evidence of hemorrhage. She was referred to our hospital at 26 weeks of gestation. Cabergoline treatment was reinstated and well tolerated by the patient. Doses were increased to 2 mg per week because bitemporal hemianopia was not improving. A subsequent noncontrast MRI scan performed at 35 weeks of gestation demonstrated a further increase in adenoma size, measuring 17 × 21 × 13 mm, with signs of intratumoral bleeding. A planned cesarean section was performed at 39 weeks of gestation, without encountering maternal–fetal complications. Breastfeeding was not initiated due to the adenoma’s compression of the chiasm. Accordingly, dopamine agonist therapy was continued. During the postpartum follow‐up, the patient experienced a resumption of menstrual cycles, normalization of prolactin levels, and a reduction in tumor size. Ultimately, the diagnosis was established as a microprolactinoma, which had enlarged during pregnancy due to a pituitary tumor apoplexy. Although microprolactinomas typically carry a low risk of symptomatic tumor growth during pregnancy, this case emphasizes the critical importance of vigilant clinical monitoring to swiftly detect and manage this rare complication. This instance serves as an educational example of an uncommon event—a microprolactinoma experiencing apoplexy during pregnancy.
- Open Access
- 11 January 2024
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1351471
Editorial: Insights in hyperprolactinemia
Editorial: Insights in hyperprolactinemia
- 11 January 2024
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1351471
Open AccessEditorial: Insights in hyperprolactinemia
Editorial: Insights in hyperprolactinemia
- Open Access
- 1 December 2023
- Published by Revista Medica del Uruguay in REVISTA MEDICA DEL URUGUAY
- Vol. 39 (4) , e701
Displasia septo-óptica (síndrome de De Morsier) con hipopituitarismo y sus múltiples complicaciones
Presentamos el caso de una paciente con displasia septo-óptica (SOD), también conocida como síndrome de De Morsier, un desorden congénito raro. Se caracteriza por una combinación de alteraciones: hipoplasia del nervio óptico, disfunción hipofisaria y anormalidades de la línea media. Presentamos el caso de una paciente de 37 años con síndrome de De Morsier que consulta por infertilidad. Asocia hipopituitarismo, con déficit de hormona de crecimiento e hipogonadismo hipogonadotrófico, diagnosticada a los 11 años, en contexto de hipocrecimiento e impuberismo. También presenta complicaciones asociadas a estos déficits, como infertilidad, síndrome metabólico y compromiso óseo. Un diagnóstico y tratamiento temprano puede prevenir la morbimortalidad asociada a este síndrome, pero no así la infertilidad. Sin embargo, es posible lograr el embarazo mediante inducción de la ovulación.
- 1 December 2023
- Published by Revista Medica del Uruguay in REVISTA MEDICA DEL URUGUAY
- Vol. 39 (4) , e701
Open AccessDisplasia septo-óptica (síndrome de De Morsier) con hipopituitarismo y sus múltiples complicaciones
Presentamos el caso de una paciente con displasia septo-óptica (SOD), también conocida como síndrome de De Morsier, un desorden congénito raro. Se caracteriza por una combinación de alteraciones: hipoplasia del nervio óptico, disfunción hipofisaria y anormalidades de la línea media. Presentamos el caso de una paciente de 37 años con síndrome de De Morsier que consulta por infertilidad. Asocia hipopituitarismo, con déficit de hormona de crecimiento e hipogonadismo hipogonadotrófico, diagnosticada a los 11 años, en contexto de hipocrecimiento e impuberismo. También presenta complicaciones asociadas a estos déficits, como infertilidad, síndrome metabólico y compromiso óseo. Un diagnóstico y tratamiento temprano puede prevenir la morbimortalidad asociada a este síndrome, pero no así la infertilidad. Sin embargo, es posible lograr el embarazo mediante inducción de la ovulación.
- Open Access
- 27 September 2023
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1254180
Strikingly low prevalence of pituitary incidentalomas in a teaching hospital in Uruguay
Background: Pituitary incidentalomas are an occurrence documented in 10.6% of post-mortem examinations, 4%–20% of computed tomography (CT) scans, and 10%–38% of magnetic resonance imaging (MRI) cases, primarily consisting of microincidentalomas (<1 cm in size). However, the prevalence of pituitary incidentalomas in Uruguay remains unexplored. This study aimed to ascertain the prevalence of pituitary incidentalomas at our hospital.Methods: In this investigation, we retrospectively identified patients who underwent brain CT and MRI at our hospital over a 1-year span due to conditions other than suspected or known pituitary disorders. The time frame covered was from 1 January to 31 December 2017. Our analysis encompassed all scans, and we conducted interviews with patients discovered to have pituitary incidentalomas. Furthermore, we conducted biochemical assessments in accordance with clinical and imaging traits.Results: During the study period, a total of 3,894 patients underwent imaging procedures. Of these, 1,146 patients underwent MRI scans, and 2,748 underwent CT scans. The mean age was 53.1 ± 19 years, with a relatively even distribution between genders (50.6% women). The majority of imaging requisitions originated from the emergency department (43%), followed by outpatient clinics (29%), and inpatient wards (28%). Common reasons for imaging requests included trauma (20.4%), headaches (11.3%), and stroke (10.9%). Among these cases, two pituitary incidentalomas were detected, resulting in a prevalence of 5 cases per 10,000 individuals annually (0.051%). Both of these cases were initially identified through CT scans, with subsequent MRI scans performed for further assessment. The final diagnoses were a vascular aneurysm and a sellar meningioma, with the latter patient also exhibiting secondary hypothyroidism. Notably, no instances of pituitary adenomas were encountered.Conclusions: The prevalence of pituitary incidentalomas within our hospital was notably low. Further research is necessary to more comprehensively investigate the occurrence of pituitary incidentalomas in our country.
- 27 September 2023
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1254180
Open AccessStrikingly low prevalence of pituitary incidentalomas in a teaching hospital in Uruguay
Background: Pituitary incidentalomas are an occurrence documented in 10.6% of post-mortem examinations, 4%–20% of computed tomography (CT) scans, and 10%–38% of magnetic resonance imaging (MRI) cases, primarily consisting of microincidentalomas (<1 cm in size). However, the prevalence of pituitary incidentalomas in Uruguay remains unexplored. This study aimed to ascertain the prevalence of pituitary incidentalomas at our hospital.Methods: In this investigation, we retrospectively identified patients who underwent brain CT and MRI at our hospital over a 1-year span due to conditions other than suspected or known pituitary disorders. The time frame covered was from 1 January to 31 December 2017. Our analysis encompassed all scans, and we conducted interviews with patients discovered to have pituitary incidentalomas. Furthermore, we conducted biochemical assessments in accordance with clinical and imaging traits.Results: During the study period, a total of 3,894 patients underwent imaging procedures. Of these, 1,146 patients underwent MRI scans, and 2,748 underwent CT scans. The mean age was 53.1 ± 19 years, with a relatively even distribution between genders (50.6% women). The majority of imaging requisitions originated from the emergency department (43%), followed by outpatient clinics (29%), and inpatient wards (28%). Common reasons for imaging requests included trauma (20.4%), headaches (11.3%), and stroke (10.9%). Among these cases, two pituitary incidentalomas were detected, resulting in a prevalence of 5 cases per 10,000 individuals annually (0.051%). Both of these cases were initially identified through CT scans, with subsequent MRI scans performed for further assessment. The final diagnoses were a vascular aneurysm and a sellar meningioma, with the latter patient also exhibiting secondary hypothyroidism. Notably, no instances of pituitary adenomas were encountered.Conclusions: The prevalence of pituitary incidentalomas within our hospital was notably low. Further research is necessary to more comprehensively investigate the occurrence of pituitary incidentalomas in our country.
- Open Access
- 25 November 2022
- Published by Wiley in Case Reports in Endocrinology
- Vol. 2022, 1-11
Acute Sheehan’s Syndrome Presenting with Hyponatremia Followed by a Spontaneous Pregnancy
Background. Acute Sheehans syndrome is rare, as well as hyponatremia as its initial manifestation. In addition, spontaneous pregnancy in patients after Sheehans syndrome is unusual. To our knowledge, no cases of spontaneous pregnancy after acute Sheehans syndrome have been reported. We describe a case of Sheehans syndrome that presented with acute hyponatremia and a spontaneous pregnancy. Case. A 34-year-old female developed blood loss during delivery, which required a blood transfusion. On day seven postpartum, she presented with headaches, lethargy, and difficulty in breastfeeding. The workup showed hyponatremia (118mEq/l), secondary hypothyroidism, and low prolactin levels. Magnetic resonance imaging showed pituitary necrosis. She was treated with NaCl, hydrocortisone (cortisol results were not available), and levothyroxine. Laboratory tests six weeks after discharge showed low IGF-1 and 8 AM cortisol and normal FT4, LH, FSH, and PRL levels. She was able to partially breastfeed until 4 months postpartum. Regular menstrual cycles started three months later. She became spontaneously pregnant one year later. Conclusion. Acute Sheehans syndrome should be considered in the evaluation of postpartum patients with suggestive symptoms. Physicians should be aware that hyponatremia could be an initial manifestation of Sheehans syndrome, which requires a high index of suspicion for diagnosis. Spontaneous pregnancy can occur after acute Sheehans syndrome.
- 25 November 2022
- Published by Wiley in Case Reports in Endocrinology
- Vol. 2022, 1-11
Open AccessAcute Sheehan’s Syndrome Presenting with Hyponatremia Followed by a Spontaneous Pregnancy
Background. Acute Sheehans syndrome is rare, as well as hyponatremia as its initial manifestation. In addition, spontaneous pregnancy in patients after Sheehans syndrome is unusual. To our knowledge, no cases of spontaneous pregnancy after acute Sheehans syndrome have been reported. We describe a case of Sheehans syndrome that presented with acute hyponatremia and a spontaneous pregnancy. Case. A 34-year-old female developed blood loss during delivery, which required a blood transfusion. On day seven postpartum, she presented with headaches, lethargy, and difficulty in breastfeeding. The workup showed hyponatremia (118mEq/l), secondary hypothyroidism, and low prolactin levels. Magnetic resonance imaging showed pituitary necrosis. She was treated with NaCl, hydrocortisone (cortisol results were not available), and levothyroxine. Laboratory tests six weeks after discharge showed low IGF-1 and 8 AM cortisol and normal FT4, LH, FSH, and PRL levels. She was able to partially breastfeed until 4 months postpartum. Regular menstrual cycles started three months later. She became spontaneously pregnant one year later. Conclusion. Acute Sheehans syndrome should be considered in the evaluation of postpartum patients with suggestive symptoms. Physicians should be aware that hyponatremia could be an initial manifestation of Sheehans syndrome, which requires a high index of suspicion for diagnosis. Spontaneous pregnancy can occur after acute Sheehans syndrome.
- Open Access
- 20 July 2021
- Published by Springer Nature in Pituitary
- Vol. 25 (1) , 64-73
Pituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas
Purpose: In adults and children, transsphenoidal surgery (TSS) represents the cornerstone of management for most large or functioning sellar lesions with the exception of prolactinomas. Endocrine evaluation and management are an essential part of perioperative care. However, the details of endocrine assessment and care are not universally agreed upon.Methods: To build consensus on the endocrine evaluation and management of adults undergoing TSS, a Delphi process was used. Thirty-five statements were developed by the Pituitary Society’s Education Committee. Fifty-five pituitary endocrinologists, all members of the Pituitary Society, were invited to participate in two Delphi rounds and rate their extent of agreement with statements pertaining to perioperative endocrine evaluation and management, using a Likert-type scale. Anonymized data on the proportion of panelists’ agreeing with each item were summarized. A list of items that achieved consensus, based on predefined criteria, was tabulated.Results: Strong consensus (≥ 80% of panelists rating their agreement as 6–7 on a scale from 1 to 7) was achieved for 68.6% (24/35) items. If less strict agreement criteria were applied (ratings 5–7 on the Likert-type scale), consensus was achieved for 88% (31/35) items.Conclusions: We achieved consensus on a large majority of items pertaining to perioperative endocrine evaluation and management using a Delphi process. This provides an international real-world clinical perspective from an expert group and facilitates a framework for future guideline development. Some of the items for which consensus was not reached, including the assessment of immediate postoperative remission in acromegaly or Cushing’s disease, represent areas where further research is needed.
- 20 July 2021
- Published by Springer Nature in Pituitary
- Vol. 25 (1) , 64-73
Open AccessPituitary Society Delphi Survey: An international perspective on endocrine management of patients undergoing transsphenoidal surgery for pituitary adenomas
Purpose: In adults and children, transsphenoidal surgery (TSS) represents the cornerstone of management for most large or functioning sellar lesions with the exception of prolactinomas. Endocrine evaluation and management are an essential part of perioperative care. However, the details of endocrine assessment and care are not universally agreed upon.Methods: To build consensus on the endocrine evaluation and management of adults undergoing TSS, a Delphi process was used. Thirty-five statements were developed by the Pituitary Society’s Education Committee. Fifty-five pituitary endocrinologists, all members of the Pituitary Society, were invited to participate in two Delphi rounds and rate their extent of agreement with statements pertaining to perioperative endocrine evaluation and management, using a Likert-type scale. Anonymized data on the proportion of panelists’ agreeing with each item were summarized. A list of items that achieved consensus, based on predefined criteria, was tabulated.Results: Strong consensus (≥ 80% of panelists rating their agreement as 6–7 on a scale from 1 to 7) was achieved for 68.6% (24/35) items. If less strict agreement criteria were applied (ratings 5–7 on the Likert-type scale), consensus was achieved for 88% (31/35) items.Conclusions: We achieved consensus on a large majority of items pertaining to perioperative endocrine evaluation and management using a Delphi process. This provides an international real-world clinical perspective from an expert group and facilitates a framework for future guideline development. Some of the items for which consensus was not reached, including the assessment of immediate postoperative remission in acromegaly or Cushing’s disease, represent areas where further research is needed.
- Open Access
- 1 January 2021
- Published by Revista Medica del Uruguay in REVISTA MEDICA DEL URUGUAY
- Vol. 37 (2) , e37211
Petrosal sinus sampling for etiological diagnosis of Cushing's syndrome: first experience in Uruguay
Identifying the cause of adrenocorticotropin (ACTH)-dependent Cushing's syndrome is key to define the appropriate treatment. Hypersecretion of the adrenocorticotropic hormone (ACTH) is mainly caused by a pituitary tumor (Cushing's syndrome) or, in 10% to 20% of cases, by tumors with ectopic production of this hormone. Differentiation between these two etiologiesmay not be easy due to the low sensitivity and specificity of noninvasive tests. Bilateral sampling of the lower petrosal sinus is the gold standard to differentiate between a pituitary and an ectopic origin, showing the pituitary ACHT hypersecretion and recording the central-to-peripheral ACTH gradient in the tumor's drainage. Despite it being highly recommended for all cases of ACTH-dependent Cushing's syndrome, it is reserved for patients with a diagnosis of hypercortisolism and negative or misleading findings in the MRI of the sellar region. The study presents the first case of petrosal sinus sampling for diagnostic purposes in Uruguay, in a 55-year-old woman with ACHT-dependent hypercortisolism showing an adenohypophysis image< 6mm. The petrosal-peripheral gradient confirmed the diagnosis of Cushing's syndrome and no complications arose during the procedure. Afterwards a transsphenoidal surgery was performed for resection of the adenoma. Evolution was good and immunochemistry confirmed the tumor's etiology.
- 1 January 2021
- Published by Revista Medica del Uruguay in REVISTA MEDICA DEL URUGUAY
- Vol. 37 (2) , e37211
Open AccessPetrosal sinus sampling for etiological diagnosis of Cushing's syndrome: first experience in Uruguay
Identifying the cause of adrenocorticotropin (ACTH)-dependent Cushing's syndrome is key to define the appropriate treatment. Hypersecretion of the adrenocorticotropic hormone (ACTH) is mainly caused by a pituitary tumor (Cushing's syndrome) or, in 10% to 20% of cases, by tumors with ectopic production of this hormone. Differentiation between these two etiologiesmay not be easy due to the low sensitivity and specificity of noninvasive tests. Bilateral sampling of the lower petrosal sinus is the gold standard to differentiate between a pituitary and an ectopic origin, showing the pituitary ACHT hypersecretion and recording the central-to-peripheral ACTH gradient in the tumor's drainage. Despite it being highly recommended for all cases of ACTH-dependent Cushing's syndrome, it is reserved for patients with a diagnosis of hypercortisolism and negative or misleading findings in the MRI of the sellar region. The study presents the first case of petrosal sinus sampling for diagnostic purposes in Uruguay, in a 55-year-old woman with ACHT-dependent hypercortisolism showing an adenohypophysis image< 6mm. The petrosal-peripheral gradient confirmed the diagnosis of Cushing's syndrome and no complications arose during the procedure. Afterwards a transsphenoidal surgery was performed for resection of the adenoma. Evolution was good and immunochemistry confirmed the tumor's etiology.